Cargando…

Recent Advances and Potential Multi-Omics Approaches in the Early Phases of Inflammatory Bowel Disease

Inflammatory bowel disease leads to debilitating gastrointestinal symptoms and reduced quality of life, resulting in a significant burden on healthcare utilization and costs. Despite substantial advancements in diagnosis and treatment, there may still be considerable delays in diagnosing some patien...

Descripción completa

Detalles Bibliográficos
Autores principales:	Rodríguez-Lago, Iago, Blackwell, Jonathan, Mateos, Beatriz, Marigorta, Urko M., Barreiro-de Acosta, Manuel, Pollok, Richard
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10218872/ https://www.ncbi.nlm.nih.gov/pubmed/37240524 http://dx.doi.org/10.3390/jcm12103418

Ejemplares similares

Diagnosis and natural history of preclinical and early inflammatory bowel disease
por: Rodríguez-Lago, Iago, et al.
Publicado: (2020)

COVID-19 and inflammatory bowel disease: Questions arising from patient care and follow-up during the initial phase of the pandemic (February–April 2020)()
por: Marín-Jiménez, Ignacio, et al.
Publicado: (2020)

Subclinical bowel inflammation increases healthcare resources utilization and steroid use before diagnosis of inflammatory bowel disease
por: Rodríguez‐Lago, Iago, et al.
Publicado: (2022)

SARS-CoV-2 vaccine acceptance among gastroenterologists and inflammatory bowel disease patients: VACUNEII project
por: Ferreiro-Iglesias, Rocío, et al.
Publicado: (2022)

SARS-CoV-2 vaccine acceptance among gastroenterologists and inflammatory bowel disease patients: VACUNEII project
por: Ferreiro-Iglesias, Rocío, et al.
Publicado: (2022)

Mild to moderate ulcerative colitis: Call me by my name
por: Rodríguez‐Lago, Iago, et al.
Publicado: (2022)

How to Optimize Treatment With Ustekinumab in Inflammatory Bowel Disease: Lessons Learned From Clinical Trials and Real-World Data
por: Gutiérrez, Ana, et al.
Publicado: (2021)

Surfing the web as a patient with IBD: New horizons
por: Rodríguez‐Lago, Iago, et al.
Publicado: (2023)

Modifying the natural history of gastrointestinal diseases in Europe as a result of early diagnosis: From eosinophilic esophagitis to inflammatory bowel disease
por: Molina‐Infante, Javier, et al.
Publicado: (2022)

Multi-omics of the gut microbial ecosystem in inflammatory bowel diseases
por: Lloyd-Price, Jason, et al.
Publicado: (2019)

Bowel Location Rather Than Disease Subtype Dominates Transcriptomic Heterogeneity in Pediatric IBD
por: Venkateswaran, Suresh, et al.
Publicado: (2018)

A simulation study of gene-by-environment interactions in GWAS implies ample hidden effects
por: Marigorta, Urko M., et al.
Publicado: (2014)

High Trans-ethnic Replicability of GWAS Results Implies Common Causal Variants
por: Marigorta, Urko M., et al.
Publicado: (2013)

Disease-specific regulation of gene expression in a comparative analysis of juvenile idiopathic arthritis and inflammatory bowel disease
por: Mo, Angela, et al.
Publicado: (2018)

Multi-omic modelling of inflammatory bowel disease with regularized canonical correlation analysis
por: Revilla, Lluís, et al.
Publicado: (2021)

Tailoring Multi-omics to Inflammatory Bowel Diseases: All for One and One for All
por: Sudhakar, Padhmanand, et al.
Publicado: (2022)

Stool multi-omics for the study of host–microbe interactions in inflammatory bowel disease
por: Sauceda, Consuelo, et al.
Publicado: (2022)

Local genetic variation of inflammatory bowel disease in Basque population and its effect in risk prediction
por: Garcia-Etxebarria, Koldo, et al.
Publicado: (2022)

Pervasive Modulation of Obesity Risk by the Environment and Genomic Background
por: Nagpal, Sini, et al.
Publicado: (2018)

COVID-19 y enfermedad inflamatoria intestinal: preguntas surgidas de la atención y seguimiento de los pacientes durante la fase inicial de la pandemia (febrero-abril 2020)
por: Marín-Jiménez, Ignacio, et al.
Publicado: (2020)

Recent advances in inflammatory bowel disease
por: Al Dulaimi, David
Publicado: (2015)

Recent advances in inflammatory bowel disease
por: Polewiczowska, Beata, et al.
Publicado: (2017)

Expression quantitative trait locus analysis for translational medicine
por: Gibson, Greg, et al.
Publicado: (2015)

Antidepressant medication use in Inflammatory Bowel Disease: a nationally representative population‐based study
por: Jayasooriya, Nishani, et al.
Publicado: (2022)

Renal and Urological Disorders Associated With Inflammatory Bowel Disease
por: Kumar, Shankar, et al.
Publicado: (2022)

Adaptive evolution of loci covarying with the human African Pygmy phenotype
por: Mendizabal, Isabel, et al.
Publicado: (2012)

Role of Quality of Life as Endpoint for Inflammatory Bowel Disease Treatment
por: Calviño-Suárez, Cristina, et al.
Publicado: (2021)

Application of single-cell omics in inflammatory bowel disease
por: Zheng, Hengqi Betty
Publicado: (2023)

Characteristics and Prognosis of Patients With Inflammatory Bowel Disease During the SARS-CoV-2 Pandemic in the Basque Country (Spain)
por: Rodríguez-Lago, Iago, et al.
Publicado: (2020)

Recent Advances in Integrative Multi-Omics Research in Breast and Ovarian Cancer
por: Khella, Christen A., et al.
Publicado: (2021)

PART of the WHOLE: A Case Study in Wellness-Oriented Personalized Medicine
por: Gibson, Greg, et al.
Publicado: (2015)

Application of Artificial Intelligence Modeling Technology Based on Multi-Omics in Noninvasive Diagnosis of Inflammatory Bowel Disease
por: Huang, Qiongrong, et al.
Publicado: (2021)

Microbiome and metabolome features in inflammatory bowel disease via multi-omics integration analyses across cohorts
por: Ning, Lijun, et al.
Publicado: (2023)

The impact of thiopurines on surgical outcomes in inflammatory bowel disease: do they make a difference?
por: Chhaya, Vivek, et al.
Publicado: (2013)

Recent human evolution has shaped geographical differences in susceptibility to disease
por: Marigorta, Urko M, et al.
Publicado: (2011)

Missing data in multi-omics integration: Recent advances through artificial intelligence
por: Flores, Javier E., et al.
Publicado: (2023)

Classical and recent advances in the treatment of inflammatory bowel diseases
por: Sales-Campos, H., et al.
Publicado: (2014)

Advancing the precision management of inflammatory bowel disease in the era of omics approaches and new technology
por: Liu, Xin-Yu, et al.
Publicado: (2023)

The 1000IBD project: multi-omics data of 1000 inflammatory bowel disease patients; data release 1
por: Imhann, Floris, et al.
Publicado: (2019)

Multi-Omics Analysis of Gut Microbiota in Inflammatory Bowel Diseases: What Benefits for Diagnostic, Prognostic and Therapeutic Tools?
por: Lacroix, Vickie, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_igggjt4hsh1kvlq3sequ87jnkc